Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 10/18/22 → 6/7/25 |
Funding
- Clinical Trial Services: $249,338.00
22-GI-126-BE-PMC: BXQ-350.AG, A Phase 1b/2 Placebo Controlled, Double Blinded Study on the Efficacy and Safety of BXQ-350 in Combination with mFOLFOX7 and Bevacizumab in Newly Diagnosed Metastatic Colorectal Carcinoma
- Patel, Reema (PI)